Extracellular ATP could more strongly enhance IL-6 production in systemic sclerosis fibroblasts than in normal fibroblasts, which was significantly inhibited by selective P2Y2 receptor antagonists AR-C118925XX. This evidence concerns the gene IL6 and systemic sclerosis.